Puneet Souda (Leerink Partners) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Puneet Souda's stock ratings?

About 63% of Puneet's ratings were profitable over a one-year hold, with an average return of +14.4% per rating, measured by 13Foresight from historical prices.

Q: How is Puneet ranked?

Puneet Souda is ranked #1412 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Puneet Souda

Puneet Souda

Leerink Partners

Wall Street Analyst

★★★☆☆

#1412

on 13Foresight · ranked by our own returns

63%

Success Rate

+14.4%

Average Return

19 of 30 calls profitable · -1.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 63% of Puneet Souda's ratings turned a profit when each position was held for 1 year — averaging +14.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

55 Buy 19 Hold 0 Sell

Puneet's Stock Coverage 32 ratings · 2026-06-19

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
GH Guardant Health	Jun 02, 2026	BUY	Strong Buy -5.8% avg upside 30 analysts	—	-0.8%
ALMR Alamar Biosciences, Inc.	May 12, 2026	BUY	Strong Buy +39.4% avg upside 5 analysts	$35.00 73.30% Upside	·
TWST Twist Bioscience	May 05, 2026	BUY	Strong Buy -25.5% avg upside 14 analysts	$70.00 15.56% Downside	+49.8%
NEO NeoGenomics	Apr 29, 2026	BUY	Strong Buy +40.2% avg upside 17 analysts	$25.00 140.77% Upside	+24.4%
TMO Thermo Fisher	Oct 23, 2025	BUY	Strong Buy +26.9% avg upside 38 analysts	$580.00 25.56% Upside	-17.2%
DHR Danaher	Oct 22, 2025	BUY	Strong Buy +21.8% avg upside 45 analysts	$235.00 32.12% Upside	-16.6%
RVTY Revvity	Sep 16, 2025	BUY	Buy +5.5% avg upside 23 analysts	$110.00 12.47% Upside	+14.9%
RGEN Repligen	Sep 11, 2025	BUY	Strong Buy +28.3% avg upside 25 analysts	$200.00 49.76% Upside	+2.3%
QTRX Quanterix	Sep 10, 2025	HOLD	Buy +464.7% avg upside 8 analysts	$6.00 108.38% Upside	-41.8%
BRKR Bruker	Sep 07, 2025	BUY	Buy -7.0% avg upside 22 analysts	—	+78.4%
A Agilent	Sep 01, 2025	BUY	Strong Buy +3.9% avg upside 32 analysts	$140.00 12.69% Upside	+6.6%
NTRA Natera	Aug 18, 2025	BUY	Strong Buy +7.6% avg upside 26 analysts	—	+40.5%
TXG 10x Genomics	Aug 11, 2025	HOLD	Buy -26.8% avg upside 18 analysts	$16.00 50.19% Downside	+157.9%
OABI OmniAb	Aug 07, 2025	BUY	Strong Buy +249.1% avg upside 10 analysts	$10.00 392.68% Upside	+21.3%
VCYT Veracyte	Aug 07, 2025	BUY	Strong Buy -19.0% avg upside 17 analysts	$45.00 12.19% Downside	+39.0%
MASS 908 Devices	Aug 06, 2025	BUY	Strong Buy +26.5% avg upside 4 analysts	$12.00 39.90% Upside	+5.7%
MYGN Myriad Genetics	Aug 06, 2025	HOLD	Hold +315.3% avg upside 24 analysts	$9.00 105.53% Upside	-31.0%
CYRX CryoPort	Aug 06, 2025	BUY	Strong Buy -3.8% avg upside 15 analysts	$16.00 9.76% Upside	+50.2%
TECH Bio-Techne	Aug 05, 2025	BUY	Strong Buy +38.6% avg upside 21 analysts	—	+3.2%
CSTL Castle Biosciences	Aug 05, 2025	BUY	Strong Buy +98.2% avg upside 9 analysts	$35.00 72.77% Upside	-6.0%
WAT Waters	Aug 05, 2025	BUY	Strong Buy +3.5% avg upside 30 analysts	$340.00 4.75% Downside	+27.2%
ILMN Illumina	Aug 01, 2025	BUY	Buy -10.0% avg upside 30 analysts	$120.00 24.47% Downside	+68.1%
LINK Interlink Electronics	Jul 29, 2025	BUY	Strong Buy +117.4% avg upside 16 analysts	—	+7.2%
HHS Harte-Hanks	Jun 01, 2025	BUY	Buy 2 analysts	—	-42.4%
ABCL AbCellera Biologics	May 09, 2025	BUY	Strong Buy +139.4% avg upside 15 analysts	$5.00 8.18% Downside	+158.1%
SNDA Sonida Senior Living	May 07, 2024	BUY	Buy +150.0% avg upside 12 analysts	—	-26.6%
AB AllianceBernstein	Dec 19, 2023	BUY	Buy +2.9% avg upside 8 analysts	—	+18.3%
SVRN OceanPal Inc	Jun 13, 2023	HOLD	Strong Buy 6 analysts	—	·
DMRA Damora Therapeutics	Apr 29, 2022	BUY	Strong Buy +28.3% avg upside 19 analysts	$16.00 25.27% Downside	·
TTOO T2 Biosystems	Aug 24, 2021	BUY	Buy +1473337.5% avg upside 10 analysts	$3.00 749900.08% Upside	·
HTGMQ HTG Molecular Diagnostics	Aug 24, 2021	BUY	Buy +7333233.3% avg upside 6 analysts	$10.00 9999900.04% Upside	·
BAX Baxter International	Oct 20, 2014	BUY	Hold +50.4% avg upside 23 analysts	$80.00 312.61% Upside	-4.8%

🔒 27 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Puneet Souda — Frequently Asked Questions

How accurate are Puneet Souda's stock ratings?

Based on the calls 13Foresight could measure, about 63% of Puneet's ratings were profitable over a one-year hold, with an average return of +14.4% per rating, or -1.0% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Puneet ranked on 13Foresight?

Puneet Souda is currently ranked #1412 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Puneet cover?

Puneet most recently has ratings on GH, ALMR, TWST, NEO, TMO, DHR, RVTY, RGEN, QTRX, BRKR, A, NTRA and 20 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!